Price Alert

Harmony Biosciences Inc. (HRMY)

NASDAQ: HRMY · Real-Time Price · USD

36.88

0.37 (1.01%)

At close: Aug 15, 2025, 3:59 PM

36.87

-0.03%

After-hours: Aug 15, 2025, 04:10 PM EDT

Harmony Biosciences Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021
Period Ending	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021
Revenue	772.53M	744.85M	714.73M	681.88M	656.11M	617.51M	582.02M	541.92M	498.86M	471.67M	437.86M	400.76M	364.29M	331.08M	305.44M	270.51M	235.39M	199.58M
Cost of Revenue	167.33M	167.29M	168.74M	157.48M	147M	133.9M	121.24M	104.97M	95.63M	89.55M	83.48M	74.41M	66.06M	59.82M	55.52M	47.62M	40.9M	34.67M
Gross Profit	605.19M	577.57M	546M	524.4M	509.11M	483.61M	460.79M	436.95M	403.22M	382.12M	354.37M	326.35M	298.23M	271.25M	249.92M	222.9M	194.49M	164.9M
Operating Income	221.86M	195.04M	190.83M	175.29M	178.09M	203.64M	192.03M	199.45M	146.84M	133.05M	120.19M	101.2M	110.36M	100.55M	87.53M	66.66M	55.98M	39.98M
Interest Income	19.75M	19.16M	18.54M	18.16M	17.34M	16.07M	14.73M	10.63M	6.53M	3.09M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Pretax Income	225.14M	197.2M	191.8M	175.34M	165M	187.4M	173.4M	177.81M	133.94M	119.08M	104.69M	85.06M	66.57M	53.43M	37.43M	12.75M	25.18M	9.06M
Net Income	180.9M	152.72M	145.49M	122.63M	114.99M	137.7M	128.85M	150.75M	200.24M	189.47M	181.47M	155.67M	58.11M	48.7M	34.6M	11.68M	23.21M	9.06M
Selling & General & Admin	238.58M	230.31M	221.27M	219.56M	209.36M	200.97M	192.69M	181.65M	177.49M	172.47M	163.3M	156.9M	148.44M	137.44M	132.03M	125.7M	115.48M	104.22M
Research & Development	144.75M	158.18M	145.82M	141.47M	133.58M	84.96M	76.06M	55.85M	78.9M	76.6M	70.89M	68.25M	39.44M	33.27M	30.37M	30.53M	23.02M	20.7M
Other Expenses	n/a	37K	-104K	89K	84K	16K	159K	39K	100K	173K	169K	127K	71K	33K	15K	-16K	-16K	-20K
Operating Expenses	383.33M	382.53M	355.17M	349.1M	331.02M	279.97M	268.76M	237.5M	256.38M	249.07M	234.19M	225.14M	187.87M	170.7M	162.39M	156.24M	138.5M	124.92M
Interest Expense	8.37M	9.13M	17.5M	18.08M	20.75M	22.56M	23.76M	22.54M	19.52M	17.23M	15.67M	16.27M	17.71M	21.01M	23.97M	27.75M	29.27M	22.04M
Selling & Marketing Expenses	115.96M	114.39M	110.92M	110.2M	106.04M	102.06M	97.4M	91.59M	88.64M	84.27M	79.28M	77.32M	73.33M	70.19M	68.12M	66.53M	62.66M	58.08M
Cost & Expenses	550.66M	549.81M	523.91M	506.58M	478.01M	413.87M	389.99M	342.47M	352.02M	338.62M	317.67M	299.56M	253.93M	230.53M	217.91M	203.86M	179.41M	159.59M
Income Tax Expense	21M	21.24M	46.31M	52.71M	50.01M	49.7M	44.54M	27.05M	-66.29M	-70.39M	-76.78M	-70.61M	8.46M	4.73M	2.83M	-3.31M	-2.41M	-4.38M
Shares Outstanding (Basic)	57.47M	57.31M	57.1M	56.87M	56.8M	56.77M	58.32M	59.86M	59.97M	59.73M	59.48M	59.23M	59.06M	58.91M	58.55M	56.59M	56.94M	56.89M
Shares Outstanding (Diluted)	58.43M	58.52M	58.22M	58.1M	57.54M	57.6M	58.85M	60.68M	60.74M	61.22M	61.62M	61.21M	60.92M	60.59M	60.31M	57.72M	58.59M	58.81M
EPS (Basic)	3.16	2.67	2.56	2.15	1.98	2.35	2.16	2.52	3.36	3.19	3.06	2.63	0.98	0.83	0.60	0.21	0.41	0.16
EPS (Diluted)	3.10	2.62	2.51	2.11	1.95	2.31	2.12	2.46	3.27	3.10	2.97	2.56	0.95	0.80	0.58	0.20	0.40	0.16
EBITDA	265.05M	233.21M	224.38M	204.37M	202.5M	228.06M	216.39M	223.75M	171.1M	157.3M	143.57M	123.28M	104.96M	93.83M	80.28M	59.03M	70.22M	51.49M
EBIT	241.18M	209.25M	200.27M	195.03M	193.02M	218.56M	206.95M	199.52M	146.97M	133.22M	120.36M	75.17M	58.12M	48.28M	35.26M	40.51M	55.99M	39.98M
Depreciation & Amortization	23.87M	23.96M	24.11M	24.27M	24.41M	24.42M	24.36M	24.3M	24.26M	24.25M	23.39M	22.08M	20.69M	19.36M	18.84M	18.46M	15.76M	13.03M